Type II collagen C2C epitope in human synovial fluid and serum after knee injury - associations with molecular and structural markers of injury

Osteoarthritis and Cartilage

Volumn 23, Issue 9, 2015, Pages 1506-1512

  Kumahashi, N ^a,b   Sward P ^a   Larsson, S ^a   Lohmander, L S ^a,c   Frobell, R ^a   Struglics, A ^a  

^a LUND UNIVERSITY   (Sweden)

^b SHIMANE UNIVERSITY   (Japan)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Biomarkers; C2C; Collagen; Knee injury; Synovial fluid

Indexed keywords

AGGRECAN; BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 2; EPITOPE; GLYCOSAMINOGLYCAN POLYSULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; COLLAGEN DEGRADATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; KNEE INJURY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNOVIAL FLUID; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BIOMARKERS; COLLAGEN TYPE II; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; KNEE INJURIES; MALE; MIDDLE AGED; SYNOVIAL FLUID; TIME FACTORS; YOUNG ADULT;

EID: 84940446843     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.04.022     Document Type: Article

References (39)

1. Lohmander L.S., Englund P.M., Dahl L.L., Roos E.M. The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis. Am J Sports Med 2007, 35:1756-1769.
2. Cahue S., Sharma L., Dunlop D., Ionescu M., Song J., Lobanok T., et al. The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage 2007, 15:819-823.
3. Mullan R.H., Matthews C., Bresnihan B., FitzGerald O., King L., Poole A.R., et al. Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy. Arthritis Rheum 2007, 56:2919-2928.
4. Lohmander L.S., Dahlberg L., Ryd L., Heinegård D. Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum 1989, 32:1434-1442.
5. Dahlberg L., Ryd L., Heinegård D., Lohmander L.S. Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand 1992, 63:417-423.
6. Lohmander L.S., Hoerrner L.A., Lark M.W. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993, 36:181-189.
7. Lohmander L.S., Saxne T., Heinegård D.K. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis 1994, 53:8-13.
8. Lohmander L.S., Ionescu M., Jugessur H., Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum 1999, 42:534-544.
9. Lohmander L.S., Atley L.M., Pietka T.A., Eyre D.R. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum 2003, 48:3130-3139.
10. Larsson S., Lohmander L.S., Struglics A. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study. Arthritis Res Ther 2009, 11:R92.
11. Matyas J.R., Atley L., Ionescu M., Eyre D.R., Poole A.R. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum 2004, 50:543-552.
12. Kojima T., Mwale F., Yasuda T., Girard C., Poole A.R., Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001, 44:120-127.
13. Trumble T.N., Scarbrough A.B., Brown M.P. Osteochondral injury increases type II collagen degradation products (C2C) in synovial fluid of Thoroughbred racehorses. Osteoarthritis Cartilage 2009, 17:371-374.
14. Svoboda S.J., Harvey T.M., Owens B.D., Brechue W.F., Tarwater P.M., Cameron K.L. Changes in serum biomarkers of cartilage turnover after anterior cruciate ligament injury. Am J Sports Med 2013, 41:2108-2116.
15. Yoshida H., Kojima T., Kurokouchi K., Takahashi S., Hanamura H., Kojima M., et al. Relationship between pre-radiographic cartilage damage following anterior cruciate ligament injury and biomarkers of cartilage turnover in clinical practice: a cross-sectional observational study. Osteoarthritis Cartilage 2013, 21:831-838.
16. Kojima T., Kojima M., Noda K., Ishiguro N., Poole A.R. Influences of menopause, aging, and gender on the cleavage of type II collagen in cartilage in relationship to bone turnover. Menopause 2008, 15:133-137.
17. Poole A.R., Ionescu M., Fitzcharles M.A., Billinghurst R.C. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J Immunol Methods 2004, 294:145-153.
18. Catterall J.B., Stabler T.V., Flannery C.R., Kraus V.B. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther 2010, 12:R229.
19. Swärd P., Frobell R., Englund M., Roos H., Struglics A. Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)-a cross-sectional analysis. Osteoarthritis Cartilage 2012, 20:1302-1308.
20. Swärd P., Struglics A., Englund M., Roos H.P., Frobell R.B. Soft tissue knee injury with concomitant osteochondral fracture is associated with higher degree of acute joint inflammation. Am J Sports Med 2014, 42:1096-1102.
21. Struglics A., Hansson M., Lohmander L.S. Human aggrecanase generated synovial fluid fragment levels are elevated directly after knee injuries due to proteolysis both in the inter globular and chondroitin sulfate domains. Osteoarthritis Cartilage 2011, 19:1047-1057.
22. Jayadev C., Rout R., Price A., Hulley P., Mahoney D. Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms. J Immunol Methods 2012, 386:22-30.
23. DeSilva B., Smith W., Weiner R., Kelley M., Smolec J., Lee B., et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res 2003, 20:1885-1900.
24. Larsson S., Englund M., Struglics A., Lohmander L.S. Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis. Arthritis Res Ther 2010, 12:R230.
25. Frobell R.B., Roos H.P., Roos E.M., Hellio Le Graverand M.P., Buck R., Tamez-Pena J., et al. The acutely ACL injured knee assessed by MRI: are large volume traumatic bone marrow lesions a sign of severe compression injury?. Osteoarthritis Cartilage 2008, 16:829-836.
26. Price J.S., Till S.H., Bickerstaff D.R., Bayliss M.T., Hollander A.P. Degradation of cartilage type II collagen precedes the onset of osteoarthritis following anterior cruciate ligament rupture. Arthritis Rheum 1999 Nov, 42(11):2390-2398.
27. Eckstein F., Wirth W., Lohmander L.S., Hudelmaier M.I., Frobell R.B. Five-year follow-up of knee joint cartilage thickness changes after acute anterior cruciate ligament rupture. Arthritis Rheumatol 2015, 67:152-161.
28. Jubb R.W., Fell H.B. The breakdown of collagen by chondrocytes. J Pathol 1980, 130:159-167.
29. Irie K., Uchiyama E., Iwaso H. Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee 2003, 10:93-96.
30. Higuchi H., Shirakura K., Kimura M., Terauchi M., Shinozaki T., Watanabe H., et al. Changes in biochemical parameters after anterior cruciate ligament injury. Int Orthop 2006, 30:43-47.
31. Kijowski R., Sanogo M.L., Lee K.S., Munoz Del Rio A., McGuine T.A., Baer G.S., et al. Short-term clinical importance of osseous injuries diagnosed at MR imaging in patients with anterior cruciate ligament tear. Radiology 2012, 264:531-541.
32. Ivaska K.K., Hentunen T.A., Vaaraniemi J., Ylipahkala H., Pettersson K., Vaananen H.K. Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro. J Biol Chem 2004, 279:18361-18369.
33. Alford A.I., Hankenson K.D. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 2006, 38:749-757.
34. Lund S.A., Giachelli C.M., Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009, 3:311-322.
35. Pan J., Wang B., Li W., Zhou X., Scherr T., Yang Y., et al. Elevated cross-talk between subchondral bone and cartilage in osteoarthritic joints. Bone 2012, 51:212-217.
36. Cibere J., Zhang H., Garnero P., Poole A.R., Lobanok T., Saxne T., et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 2009, 60:1372-1380.
37. Mazzuca S.A., Poole A.R., Brandt K.D., Katz B.P., Lane K.A., Lobanok T. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J Rheumatol 2006, 33:1147-1151.
38. King K.B., Lindsey C.T., Dunn T.C., Ries M.D., Steinbach L.S., Majumdar S. A study of the relationship between molecular biomarkers of joint degeneration and the magnetic resonance-measured characteristics of cartilage in 16 symptomatic knees. Magn Reson Imaging 2004, 22:1117-1123.
39. Simkin P.A., Bassett J.E. Pathways of microvascular permeability in the synovium of normal and diseased human knees. J Rheumatol 2011, 38:2635-2642.